Carl LeBel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Carl LeBel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Carl LeBel. Carl LeBel is Chief Scientific Officer in Otonomy, Inc. ($OTIC) and Chief Development Officer in Frequency Therapeutics, Inc. ($FREQ).
Latest Insider Trading Transactions of Carl LeBel
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Jan 19 2021 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 35.85 | 75,000 | 2,688,750 | 75,000 | |
| Feb 14 2020 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 25.05 | 57,500 | 1,440,375 | 57,500 | |
| Dec 05 2019 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 3.37 | 23,555 | 79,380 | 23,555 | |
| Oct 02 2019 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 14.00 | 178,937 | 2,505,118 | 178,937 | |
| Oct 02 2019 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 3.37 | 101,930 | 343,504 | 101,930 | |
| Oct 02 2019 | FREQ | Frequency Therapeu ... | LeBel Carl | Chief Development O ... | Option Exercise | A | 3.37 | 23,555 | 79,380 | 23,555 | |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 3.17 | 1,456 | 4,616 | 12,803 | |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 3.17 | 5,626 | 17,834 | 14,259 | |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 6.33 | 3,543 | 22,427 | 31,891 | |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 18.07 | 1,456 | 26,303 | 9,458 | 10.9 K to 9.5 K (-13.34 %) |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 3.17 | 1,456 | 4,616 | 10,914 | 9.5 K to 10.9 K (+15.39 %) |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 18.07 | 9,169 | 165,703 | 9,458 | 18.6 K to 9.5 K (-49.22 %) |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 3.17 | 5,626 | 17,834 | 18,627 | 13 K to 18.6 K (+43.27 %) |
| Nov 22 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 6.33 | 3,543 | 22,427 | 13,001 | 9.5 K to 13 K (+37.46 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 3.17 | 5,304 | 16,814 | 19,885 | |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 6.33 | 15,946 | 100,938 | 35,434 | |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 17.95 | 5,304 | 95,207 | 9,458 | 14.8 K to 9.5 K (-35.93 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 17.95 | 3,813 | 68,443 | 14,762 | 18.6 K to 14.8 K (-20.53 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 17.95 | 12,133 | 217,787 | 18,575 | 30.7 K to 18.6 K (-39.51 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 3.17 | 5,304 | 16,814 | 30,708 | 25.4 K to 30.7 K (+20.88 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 6.33 | 3,813 | 24,136 | 25,404 | 21.6 K to 25.4 K (+17.66 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 6.33 | 12,133 | 76,802 | 21,591 | 9.5 K to 21.6 K (+128.28 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Grant | A | 13.13 | 275 | 3,611 | 9,458 | 9.2 K to 9.5 K (+2.99 %) |
| Sep 08 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Grant | A | 13.60 | 263 | 3,577 | 9,183 | 8.9 K to 9.2 K (+2.95 %) |
| Mar 03 2016 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | A | 14.44 | 35,000 | 505,400 | 35,000 | |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 3.17 | 4,674 | 14,817 | 25,189 | |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 6.33 | 16,576 | 104,926 | 51,380 | |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 28.38 | 8,061 | 228,753 | 8,920 | 17 K to 8.9 K (-47.47 %) |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 27.83 | 13,189 | 367,074 | 16,981 | 30.2 K to 17 K (-43.72 %) |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 3.17 | 4,674 | 14,817 | 30,170 | 25.5 K to 30.2 K (+18.33 %) |
| Dec 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 6.33 | 16,576 | 104,926 | 25,496 | 8.9 K to 25.5 K (+185.83 %) |
| Sep 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 6.33 | 17,083 | 108,135 | 67,956 | |
| Sep 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Option Exercise | M | 1.76 | 4,167 | 7,334 | 137,284 | |
| Sep 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Sell | S | 24.36 | 21,250 | 517,576 | 8,920 | 30.2 K to 8.9 K (-70.43 %) |
| Sep 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 6.33 | 17,083 | 108,135 | 30,170 | 13.1 K to 30.2 K (+130.53 %) |
| Sep 22 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Buy | M | 1.76 | 4,167 | 7,334 | 13,087 | 8.9 K to 13.1 K (+46.72 %) |
| Jun 02 2015 | OTIC | Otonomy, Inc. | LeBel Carl | Chief Scientific Of ... | Grant | A | 13.60 | 389 | 5,290 | 389 | 0 to 389 |
Page: 1